Brinjikji Waleed, Nasr Deena M, Cloft Harry J, Iyer Vivek N, Lanzino Giuseppe
Department of Radiology, Mayo Clinic, USA
Department of Neurology, Mayo Clinic, USA.
Interv Neuroradiol. 2016 Jun;22(3):354-61. doi: 10.1177/1591019915623560. Epub 2016 Jan 27.
Although rare, spinal arteriovenous malformations (AVMs) are thought to be more prevalent in the hereditary Hereditary Hemorrhagic Telangiectasia (HHT) population.
We report a case of a spinal AVM in a 37-year-old female with HHT treated with endovascular embolization. In addition, we report findings from a systematic review of the literature on the clinical characteristics, angioarchitecture, and clinical outcomes of HHT patients with spinal AVMs.
The patient is a 37 year-old female with definite HHT who presented with a one-year history of progressive gait difficulty. The spinal fistula was incidentally detected on chest computed tomography (CT). Spinal angiography demonstrated a large perimedullary arteriovenous fistula was supplied by a posterolateral spinal artery. The fistula was treated with detachable coils. The patient made a complete neurological recovery. Our systematic review yielded 25 additional cases of spinal AVMs in HHT patients. All fistulae were perimedullary (100.0%). Treatments were described in 24 of the 26 lesions. Endovascular-only treatment was performed in 16 cases (66.6%) and surgical-only treatment was performed in five cases (20.8%). Complete or near-complete occlusion rates were 86.7% (13/15) for endovascular treated cases, 100.0% (4/4) for surgery and 66.6% (2/3) for combined treatments. Overall, 80.0% of patients (16/20) reported improvement in function following treatment, 100.0% (5/5) in the surgery group and 84.6% (11/13) reported improvement in the endovascular group.
Spinal fistulae in HHT patients are usually type IV perimedullary fistulae. Both endovascular and surgical treatments appeared to be effective in treating these lesions. However, it is clear that endovascular therapy has become the preferred treatment modality.
尽管脊髓动静脉畸形(AVM)较为罕见,但在遗传性出血性毛细血管扩张症(HHT)人群中被认为更为普遍。
我们报告了一例37岁患有HHT的女性脊髓AVM患者,采用血管内栓塞治疗。此外,我们报告了对HHT合并脊髓AVM患者的临床特征、血管结构和临床结局的文献系统评价结果。
该患者为一名37岁确诊HHT的女性,有一年渐进性步态困难病史。胸部计算机断层扫描(CT)偶然发现脊髓瘘。脊髓血管造影显示一个由脊髓后外侧动脉供血的大型髓周动静脉瘘。采用可脱性弹簧圈治疗该瘘。患者神经功能完全恢复。我们的系统评价又发现了25例HHT患者的脊髓AVM病例。所有瘘均为髓周瘘(100.0%)。26个病变中有24个描述了治疗情况。仅行血管内治疗16例(66.6%),仅行手术治疗5例(20.8%)。血管内治疗病例的完全或近乎完全闭塞率为86.7%(13/15),手术治疗为100.0%(4/4),联合治疗为66.6%(2/3)。总体而言,80.0%的患者(16/20)报告治疗后功能改善,手术组为100.0%(5/5),血管内治疗组为84.6%(11/13)。
HHT患者的脊髓瘘通常为IV型髓周瘘。血管内和手术治疗似乎对治疗这些病变均有效。然而,显然血管内治疗已成为首选的治疗方式。